Healthcare | March 22, 2022
M2 milk platform to develop cell-cultured milk
Building the future of food in the birthplace of cell-cultured milk
Building the future of food in the birthplace of cell-cultured milk
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
The company plans to launch the product immediately
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Sputnik Light is the first component of Sputnik V
Subscribe To Our Newsletter & Stay Updated
